Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma

NCT00486135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Lymphoma

Interventions

DRUG: XL147 (SAR245408)
DRUG: XL147 (SAR245408)

Sponsor

Sanofi